CD8A and neoplasm: Our results agree with existing reports [47–49] that presence of a baseline anti-tumor immune cell infiltrate or pre-existing tumor immunity [21] is associated with high levels of tumor infiltrating CD8+ T cells and strongly associated with improved patient survival.